ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260095.1	Tanespimycin	Chronic Lymphocytic Leukemia	0.02822794	Resistant
ENSG00000260095.1	Tanespimycin	Lung squamous cell carcinoma	0.027059583	Resistant